Operating Lease, Right-of-Use Asset of Edgewise Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Edgewise Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Edgewise Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,437,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Edgewise Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,437,000 -$181,000 -11% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,484,000 -$563,000 -28% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,528,000 -$667,000 -30% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,569,000 -$678,000 -30% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $1,618,000 -$679,000 -30% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $2,047,000 -$306,000 -13% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $2,195,000 -$195,000 -8.2% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $2,247,000 +$929,000 +70% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $2,297,000 +$975,000 +74% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $2,353,000 +$782,000 +50% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,390,000 +$260,000 +12% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,318,000 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $1,322,000 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $1,571,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $2,130,000 31 Mar 2022 10-Q 11 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.